Results 61 to 70 of about 4,859,269 (256)

Acute respiratory health effects of urban air pollutants in adults with different patterns of underlying respiratory disease [PDF]

open access: yes, 2012
OBJECTIVE: Whether underlying chronic respiratory diseases are susceptible factors for symptomatic episodes, which lead to primary-level care, in association with air pollutant exposures is unknown.
Tschopp, J. M.   +19 more
core   +1 more source

APPLICATION OF ANTIBACTERIAL MEDICATIONS AMONG CHILDREN, SUFFERING FROM ACUTE RESPIRATORY DISEASES IN DISPENSARY PRACTICES OF VLADIVOSTOK

open access: yesПедиатрическая фармакология, 2007
The article deals with the findings of the expert appraisal of the patient medical records of 781 children under 14 years old with symptoms of the respiratory diseases between 1999–2002. The authors analyzed the general number of prescriptions, groups of
G.N. Bondar', V.N. Luchaninova
doaj   +2 more sources

BCG vaccination potentiates oxidative phosphorylation in neonatal myeloid‐derived suppressor cells

open access: yesFEBS Open Bio, EarlyView.
BCG vaccination enhances oxidative phosphorylation in neonatal MDSCs, impairing their immunosuppressive function. It upregulates electron transport chain genes and mitochondrial activity, increasing ATP and oxygen consumption. Pharmacological OXPHOS inhibition partially restores suppressive capacity, confirming causality.
Yingying Chen, Hui Li
wiley   +1 more source

SARS-CoV antibody prevalence in all Hong Kong patient contacts. [PDF]

open access: yes, 2004
A total of 1,068 asymptomatic close contacts of patients with severe acute respiratory (SARS) from the 2003 epidemic in Hong Kong were serologically tested, and 2 (0.19%) were positive for SARS coronavirus immunoglobulin G antibody. SARS rarely manifests
Law, Y-L   +63 more
core   +1 more source

Research progress of Traditional Chinese Medicine compound against respiratory viral diseases

open access: yes生物医学转化
In recent years, according to incomplete statistics, acute respiratory infections caused by viruses account for approximately 80% of all respiratory diseases triggered by pathogenic microorganisms, making these the diseases with the highest incidence ...
Ma Wangming   +4 more
doaj   +1 more source

Antitussive Therapy in Acute Respiratory Diseases in Children

open access: yesZdorovʹe Rebenka, 2014
The article presents information about the level of effectiveness of the main groups of drugs used in treatment regimens of acute respiratory infections in children.
I.L. Vysochina   +4 more
doaj   +1 more source

Chronobiology of Cancer: How Aging Fuels Oncogenesis at the Molecular Level

open access: yesAging and Cancer, EarlyView.
This graphical abstract illustrates the key biological pathways linking aging with cancer development and progression. In the upper left, cumulative exposure to ultraviolet radiation, toxins, and reactive oxygen species (ROS) causes DNA damage and genomic instability, whereas age‐related decline in repair mechanisms, such as ATM/ATR, BER, and NER ...
Anu Singh, Aroonima Misra, Sufian Zaheer
wiley   +1 more source

Frequent travelers and rate of spread of epidemics. [PDF]

open access: yes, 2007
A small proportion of air travelers make disproportionately more journeys than the rest of travelers. They also tend to interact predominantly with other frequent travelers in hotels and airport lounges.
Anderson, RM   +8 more
core   +1 more source

CLARYTROMYCIN IN TREATMENT OF PEDIATRIC ACUTE RESPIRATORY DISEASES

open access: yesВопросы современной педиатрии, 2012
Acute respiratory diseases still occupy leading positions among all pediatric diseases. This article contains modern data upon etiology of acute and recurrent bronchitides, as well as that of out-of-hospital pneumonias in children.
A. Yu. Simonova
doaj   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy